Pemtumomab

	WikiDoc Resources for Pemtumomab
Articles
Most recent articles on Pemtumomab Most cited articles on Pemtumomab Review articles on Pemtumomab Articles on Pemtumomab in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Pemtumomab Images of Pemtumomab Photos of Pemtumomab Podcasts & MP3s on Pemtumomab Videos on Pemtumomab
Evidence Based Medicine
Cochrane Collaboration on Pemtumomab Bandolier on Pemtumomab TRIP on Pemtumomab
Clinical Trials
Ongoing Trials on Pemtumomab at Clinical Trials.gov Trial results on Pemtumomab Clinical Trials on Pemtumomab at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Pemtumomab NICE Guidance on Pemtumomab NHS PRODIGY Guidance FDA on Pemtumomab CDC on Pemtumomab
Books
Books on Pemtumomab
News
Pemtumomab in the news Be alerted to news on Pemtumomab News trends on Pemtumomab
Commentary
Blogs on Pemtumomab
Definitions
Definitions of Pemtumomab
Patient Resources / Community
Patient resources on Pemtumomab Discussion groups on Pemtumomab Patient Handouts on Pemtumomab Directions to Hospitals Treating Pemtumomab Risk calculators and risk factors for Pemtumomab
Healthcare Provider Resources
Symptoms of Pemtumomab Causes & Risk Factors for Pemtumomab Diagnostic studies for Pemtumomab Treatment of Pemtumomab
Continuing Medical Education (CME)
CME Programs on Pemtumomab
International
Pemtumomab en Espanol Pemtumomab en Francais
Business
Pemtumomab in the Marketplace Patents on Pemtumomab
Experimental / Informatics
List of terms related to Pemtumomab

Overview

Pemtumomab (formerly known as Theragyn) is a mouse monoclonal antibody which it's used to treat cancer.